This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent. Top assignees: Mogam Institute for Biomedical Research, The Green Cross Corporation. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 17 
1 out of 264 
Years Active: 2026
Title: The Innovations of Shinai Lee
Introduction
Shinai Lee is a notable inventor based in Yongin, South Korea. He has made significant contributions to the field of biomedical research, particularly in the development of innovative therapeutic proteins. His work has the potential to impact cancer treatment and immunotherapy.
Latest Patents
Shinai Lee holds a patent for a "Fusion Protein Comprising Anti-Mesothelin Antibody, Anti-CD3 Antibody or Anti-EGFR Antibody, Bispecific or Trispecific Antibody Comprising Same, and Uses Thereof." This patent highlights his focus on creating bispecific and trispecific antibodies that can target multiple pathways in cancer therapy.
Career Highlights
Throughout his career, Shinai Lee has worked with prominent organizations such as the Green Cross Corporation and the Mogam Institute for Biomedical Research. His experience in these institutions has allowed him to refine his skills and contribute to groundbreaking research in the field.
Collaborations
Shinai Lee has collaborated with talented individuals, including Aerin Yoon and Yong-Yea Park. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Shinai Lee's contributions to the field of biomedical research and his innovative patents demonstrate his commitment to advancing medical science. His work continues to inspire future developments in cancer treatment and immunotherapy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile